Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cytek Biosciences (CTKB) Return on Assets (2021 - 2025)

Cytek Biosciences (CTKB) has disclosed Return on Assets for 5 consecutive years, with 0.03% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Assets changed N/A year-over-year to 0.03%, compared with a TTM value of 0.03% through Sep 2025, changed N/A, and an annual FY2024 reading of 0.01%, up 1.0% over the prior year.
  • Return on Assets was 0.03% for Q3 2025 at Cytek Biosciences, down from 0.02% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.01% in Q4 2021 and bottomed at 0.03% in Q3 2023.
  • Average Return on Assets over 5 years is 0.01%, with a median of 0.01% recorded in 2022.
  • The sharpest move saw Return on Assets changed 0bps in 2022, then dropped -3bps in 2023.
  • Year by year, Return on Assets stood at 0.01% in 2021, then dropped by -26bps to 0.0% in 2022, then crashed by -590bps to 0.02% in 2023, then grew by 2bps to 0.02% in 2024, then fell by -12bps to 0.03% in 2025.
  • Business Quant data shows Return on Assets for CTKB at 0.03% in Q3 2025, 0.02% in Q1 2024, and 0.02% in Q4 2023.